Stock NEO NEOGENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News NeoGenomics, Inc.

Equities

NEO

US64049M2098

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/05/2024 am IST 		5-day change 1st Jan Change
13.92 USD -8.54% Intraday chart for NeoGenomics, Inc. -1.69% -13.97%
30/04 Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating MT
30/04 Earnings Flash (NEO) NEOGENOMICS Reports Q1 Revenue $156.2M, vs. Street Est of $149.7M MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating
MT
NeoGenomics: Q1 Earnings Snapshot
AQ
Earnings Flash (NEO) NEOGENOMICS Reports Q1 Revenue $156.2M, vs. Street Est of $149.7M
MT
NeoGenomics Reports First Quarter 2024 Results
BU
NeoGenomics Announces Senior Leadership Promotions
BU
NeoGenomics, Inc. Announces Senior Leadership Promotions
CI
NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics
CI
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
BU
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
BU
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
BU
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
AQ
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
BU
Piper Sandler Adjusts Price Target on NeoGenomics to $20 From $18, Maintains Overweight Rating
MT
Goldman Sachs Raises Price Target on NeoGenomics to $19 From $17, Maintains Buy Rating
MT
Needham Raises NeoGenomics' Price Target to $24 From $21, Keeps Buy Rating
MT
Traders Await Fed Minutes, Nvidia Earnings as US Equity Futures Drop Pre-Bell
MT
NeoGenomics Swings to Q4 Adjusted Earnings, Revenue Rises; Issues 2024 Guidance
MT
NeoGenomics: Q4 Earnings Snapshot
AQ
Transcript : NeoGenomics, Inc., Q4 2023 Earnings Call, Feb 20, 2024
NeoGenomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEO Stock
  4. News NeoGenomics, Inc.